Real-world evidence for pembrolizumab in non-small cell lung cancer: a nationwide cohort studyEpidemiology

被引：0
|
作者：
Helga H. Hektoen [1 ]
Kaitlyn M. Tsuruda [2 ]
Lars Fjellbirkeland [1 ]
Yngvar Nilssen [3 ]
Odd Terje Brustugun [4 ]
Bettina K. Andreassen [5 ]
机构：
[1] Norwegian Institute of Public Health,Department of Research, Cancer Registry of Norway
[2] Oslo University Hospital,Department of Cancer Genetics, Institute for Cancer Research
[3] Oslo University Hospital,Department of Respiratory Medicine
[4] University of Oslo,Institute of Clinical Medicine
[5] Cancer Registry of Norway,Department of Registration
[6] Norwegian Institute of Public Health,Section of Oncology, Drammen Hospital
[7] Vestre Viken Health Trust,undefined
来源：
British Journal of Cancer | 2025年 / 132卷 / 1期
关键词：
D O I：
10.1038/s41416-024-02895-1
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：93 / 102
页数：9
相关论文
共 50 条
  • [1] Safety of pembrolizumab in patients with non-small cell lung cancer: a real-world study
    Thakrar, D. B.
    Essang, B.
    Echlin, A.
    Murdock, C.
    Lind, M. J.
    LUNG CANCER, 2019, 127 : S40 - S41
  • [2] A real-world analysis of non-small cell lung cancer patients treated with pembrolizumab or pembrolizumab in combination with pemetrexed and platinum
    Agg, Himani
    Winfree, Katherine B.
    Zhu, Yajun Emily
    Muehlenbein, Catherine
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (05)
  • [3] Real-world effectiveness of pembrolizumab in previously treated non-small cell lung cancer: A population-based cohort study
    Murteira, Rodrigo
    Borges, Fabio Cardoso
    Mendes, Goncalo Pinto
    Ramos, Catarina
    Ramos, Adriana
    Soares, Patricia
    Furtado, Claudia
    Miranda, Ana
    da Costa, Filipa Alves
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 (10) : 1295 - 1302
  • [4] Real-world monitoring of hybrid dosing of pembrolizumab in stage IV non-small cell lung cancer in the Netherlands
    Dronkers, E.
    Van Geffen, E.
    Bekkers, C.
    Sobels, A.
    van Drie-Pierik, R.
    Eldering-Heldens, A.
    Zwaveling, J.
    Eijsink, J.
    Smit, H. J. M.
    Hilarius, D.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (04) : S73 - S73
  • [5] Real-world efficacy and safety of pembrolizumab in patients with non-small cell lung cancer: a retrospective observational study
    Cavaille, Francois
    Peretti, Mathieu
    Garcia, Marie Eve
    Giorgi, Roch
    Ausias, Nathalie
    Vanelle, Patrice
    Barlesi, Fabrice
    Montana, Marc
    TUMORI JOURNAL, 2021, 107 (01): : 32 - 38
  • [6] Real-world overall survival after alternative dosing for pembrolizumab in the treatment of non-small cell lung cancer: A nationwide retrospective cohort study with a non-inferiority primary objective
    Grit, Geeske F.
    van Geffen, Esmee
    Malmberg, Ruben
    van Leeuwen, Roelof
    Bohringer, Stefan
    Smit, Hans J. M.
    Brocken, Pepijn
    Eijsink, Job F. H.
    Dronkers, Esther
    Gal, Pim
    Jaarsma, Eva
    van Drie-Pierik, Regine J. H. M.
    Eldering-Heldens, Anne M. P.
    Wymenga, A. N. Machteld
    Mol, Peter G. M.
    Zwaveling, Juliette
    Hilarius, Doranne
    LUNG CANCER, 2024, 196
  • [7] Real-world outcomes of pembrolizumab monotherapy in non-small cell lung cancer in Japan: A post-marketing surveillance
    Yamamoto, Nobuyuki
    Kamitani, Tetsu
    Kanda, Kingo
    Ito, Yuichiro
    Hamada, Masahiro
    Ozaki, Masahiko
    Takeuchi, Noriko
    Yamada, Tomoko
    Kawano, Masaki
    Maekawa, Shinichiroh
    Kato, Terufumi
    CANCER SCIENCE, 2022, 113 (09) : 3110 - 3119
  • [8] REAL-WORLD COSTS OF LABORATORY TESTS FOR NON-SMALL CELL LUNG CANCER
    van der Linden, N.
    Smit, E. F.
    Uyl-De Groot, C. A.
    VALUE IN HEALTH, 2014, 17 (07) : A622 - A623
  • [9] Update on real-world efficacy of anlotinib in non-small cell lung cancer
    Gao, Junzhen
    Xu, Yan
    Liu, Yonggang
    Liang, Li
    Yu, Yan
    Zhao, Dahai
    Jin, Jiahui
    Wang, Mengzhao
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [10] Real-world costs of laboratory tests for non-small cell lung cancer
    van der Linden, Naomi
    Smit, Egbert F.
    Uyl-de Groot, Carin A.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2015, 53 (08) : E187 - E189
12345